-
MEDIA RELEASE | NHMRC funding awarded to tackle malaria and pneumonia on a global scale
Two top researchers from Menzies are closer to tackling life-threatening diseases and improving global health approaches after securing competitive national funding.
-
MEDIA RELEASE | Menzies researchers in the top 2 per cent
Menzies School of Health Research is celebrating the work of its researchers who have been ranked amongst the world’s top scientists.
-
Finding innovative solutions to eliminate vivax malaria by 2030
New research by Menzies’ malaria team is identifying innovative new ways to eliminate Plasmodium vivax (P. vivax) malaria by 2030.
-
Regional research set to get digital boost
Resources Regional Collaborations Programme COVID-19 Digital Grants, recognises A/Prof Kamala Ley-Thriemer, Dr Jo Wapling and Dr Chris Lowbridge.
-
Lost in translation: In search of an end to the malaria epidemic
CDU Research Impact story | Menzies researcher Dr Kamala Ley-Thriemer is committed to the cause.
-
Calls for a universal radical cure to treat malaria
The elimination of malaria from the Asia Pacific within the decade will require the safe and effective radical cure of malaria, a new paper in Trends in Parasitology suggests.
-
Calls for a universal radical cure to treat malaria
The elimination of malaria from the Asia Pacific within the decade will require the safe and effective radical cure of malaria, a new paper in Trends in Parasitology suggests.
-
Media Release | Malaria researcher awarded national fellowship
Menzies School of Health (Menzies) researcher Dr Kamala Thriemer has been awarded a prestigious $1.25 million CSL Centenary Fellowship to develop and optimise treatment programs against vivax malaria in SE Asia and the Horn of Africa.
-
Media Release | $2.5 million CSL Centenary Fellowships announced
Two Australian scientists have each been awarded AUD$1.25 million CSL Centenary Fellowships over five years to improve treatments for two of the world’s biggest health challenges: malaria and cancer.
-
New Research Pinpoints Faster Treatment to Cure Vivax Malaria
A new research study has shown that a seven-day treatment with a high dose of an anti-malaria drug can be tolerated by patients
-
New study shows faster way to cure vivax malaria
A large clinical trial in Africa and Asia has shown that a 7 day course of high dose primaquine, a drug used to treat P. vivax malaria, is well tolerated.
-
7th International Conference on Plasmodium vivax Research | Final Report
MESA Correspondents bring you cutting-edge coverage from the 7th International Conference on Plasmodium vivax Research (ICPVR 2019).
-
Coverage from the 7th International Conference on Plasmodium vivax Research
Wrapping up the 7th International Conference on Plasmodium vivax Research, day three focused on the topics of P. vivax drugs and approaches for P. vivax elimination.
-
Asia–Pacific research partnerships set to tackle big challenges
The largest grant, of $257,767, goes to the Menzies School of Health Research for a project with collaborators in Bangladesh, Indonesia and the Netherlands.
-
SMH | Commonwealth regional research grants key to 'science diplomacy'
Among the other projects funded are the Menzies School of Health Research partnering with Bangladesh, Indonesia and Nepal to develop malaria treatments.
-
Funding spotlight on eliminating malaria in Vietnam
-
Weeding out Malaria
A study led by the Menzies School of Health Research recommends a two-stage treatment for the notoriously difficult-to-cure Plasmodium vivax malaria
-
Study emphasises the need for radical cure of vivax malaria
A study into the treatment of the difficult-to-cure Plasmodium vivax malaria in Ethiopia.